Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

CVS to defend $69B merger with Aetna in upcoming court proceeding

CVS Health is gearing up to defend its $69 billion takeover of the nation’s third-largest health insurer, Aetna, The Wall Street Journal reported.

Healthcare costs top financial concerns for Americans

The most important financial problem American families face is healthcare costs, according to a new Gallup poll.

Thumbnail

CMS updates PACE program

CMS published its final rule to update the programs of all-inclusive care for the elderly (PACE), which provides comprehensive medical and social services to help keep elderly individuals who qualify for nursing homes in their homes longer.

 

Thumbnail

The annual cost of physician burnout is $4.6B

Physicians are burned out, and, left unchecked, those feelings of detachment from work come with a national cost of about $4.6 billion each year, according to new research published in the Annals of Internal Medicine.

Thumbnail

Trump order will thrust healthcare prices into limelight

The Trump administration is expected to release an executive order this week that mandates the disclosure of healthcare prices across the industry, The Wall Street Journal reported. If enacted, the executive order could turn the traditionally opaque healthcare industry on its head.

Thumbnail

AMGA survey: Risk-based revenues are rising

Members of the American Medical Group Association (AMGA), which represents more than 175,000 physicians, are bullish on taking on risk, with more member revenues coming from risk-based models in 2018, according to a recent survey on the transition to value-based care.

Thumbnail

Political uncertainty isn’t likely to drag down M&A in healthcare

Political unrest isn’t taking much of a toll on deals in healthcare, with executives still bullish on the sector, according to new data from Merrill Corp.

Thumbnail

42% of drug spending comes from private plans

Together, private health insurance, Medicare and Medicaid accounted for 82% of total prescription drug spending in the U.S. in 2017, according to a recent analysis from the Kaiser Family Foundation that broke down drug spending that year.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup